My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 307

    1.

    Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects.

    Rennings AJ, Smits P, Stewart MW, Tack CJ.

    Diabetes Care. 2006 Mar;29(3):581-7.PMID: 16505510 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

    Tack CJ, Ong MK, Lutterman JA, Smits P.

    Diabetologia. 1998 May;41(5):569-76.PMID: 9628275 [PubMed - indexed for MEDLINE]Related articles

    3.

    Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

    Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E.

    Diabetes Care. 2004 Jun;27(6):1349-57.PMID: 15161787 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives.

    Gudbjörnsdottir S, Elam M, Sellgren J, Anderson EA.

    J Hypertens. 1996 Jan;14(1):91-7.PMID: 12013500 [PubMed - indexed for MEDLINE]Related articles

    5.

    In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.

    Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P.

    Diabetes Care. 2004 Feb;27(2):484-90.PMID: 14747233 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of Intrabrachial metacholine infusion on muscle capillary recruitment and forearm glucose uptake during physiological hyperinsulinemia in obese, insulin-resistant individuals.

    Murdolo G, Sjöstrand M, Strindberg L, Gudbjörnsdóttir S, Lind L, Lönnroth P, Jansson PA.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2764-73. Epub 2008 May 6.PMID: 18460559 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    N(G)-monomethyl-L-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly.

    Meneilly GS, Elliott T, Battistini B, Floras JS.

    Metabolism. 2001 Mar;50(3):306-10.PMID: 11230783 [PubMed - indexed for MEDLINE]Related articles

    8.

    Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.

    Wang TD, Chen WJ, Cheng WC, Lin JW, Chen MF, Lee YT.

    Am J Cardiol. 2006 Oct 15;98(8):1057-62. Epub 2006 Aug 28.PMID: 17027571 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.

    Mittermayer F, Schaller G, Pleiner J, Krzyzanowska K, Kapiotis S, Roden M, Wolzt M.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2574-80. Epub 2007 May 1.PMID: 17473072 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Vascular response to angiotensin II in upper body obesity.

    Nielsen S, Halliwill JR, Joyner MJ, Jensen MD.

    Hypertension. 2004 Oct;44(4):435-41. Epub 2004 Aug 30.PMID: 15337733 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial.

    Schram MT, Stam F, de Jongh RT, de Vries G, van Dijk RA, Serné EH, Lampe D, Nanayakkara PW, Tushuizen ME, Scheffer PG, Schalkwijk CG, Kamper AM, Stehouwer CD.

    Atherosclerosis. 2003 Sep;170(1):59-72.PMID: 12957683 [PubMed - indexed for MEDLINE]Related articles

    12.

    Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

    Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA.

    Am J Clin Nutr. 2009 Jan;89(1):27-36. Epub 2008 Dec 3.PMID: 19056585 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

    Esposito K, Ciotola M, Carleo D, Schisano B, Saccomanno F, Sasso FC, Cozzolino D, Assaloni R, Merante D, Ceriello A, Giugliano D.

    Diabetes Care. 2006 May;29(5):1071-6.PMID: 16644639 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients.

    Raji A, Seely EW, Bekins SA, Williams GH, Simonson DC.

    Diabetes Care. 2003 Jan;26(1):172-8.PMID: 12502676 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [The relationship between insulin resistance and endothelium-dependent vasodilatation in obese subjects]

    Yu YR, Li HL, Yu HL, Wang C, Pu S.

    Zhonghua Yi Xue Za Zhi. 2003 Sep 10;83(17):1467-70. Chinese. PMID: 14521722 [PubMed - indexed for MEDLINE]Related articles

    16.

    Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.

    Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Järvinen H.

    Diabetes. 1999 Apr;48(4):821-7.PMID: 10102699 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Nitric oxide release accounts for insulin's vascular effects in humans.

    Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P.

    J Clin Invest. 1994 Dec;94(6):2511-5.PMID: 7989610 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.

    Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI, Kazakos KA, Yovos JG, Zebekakis PE, Tziolas IM, Tourkantonis AN.

    J Hypertens. 2004 Sep;22(9):1769-77.PMID: 15311106 [PubMed - indexed for MEDLINE]Related articles

    19.

    Chlorthalidone improves endothelial-mediated vascular responses in hypertension complicated by nondiabetic metabolic syndrome.

    Dell'Omo G, Penno G, Del Prato S, Pedrinelli R.

    J Cardiovasc Pharmacol Ther. 2005 Dec;10(4):265-72.PMID: 16382262 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.

    Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G.

    Diabetologia. 2006 Feb;49(2):351-9. Epub 2005 Dec 21.PMID: 16369774 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity